K

Kodiak Sciences
D

KOD

21.590
USD
-0.79
(-3.53%)
Post Trading
حجم التداول
13,531
الربح لكل سهم
-3
العائد الربحي
-
P/E
-5
حجم السوق
1,310,099,265
المقالات

العنوان: Kodiak Sciences

القطاع: Healthcare
الصناعة: Biotechnology
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.